
Olink Holding AB (publ)
Olink Holding AB (publ) (OLK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OLK · as of Jun 9, 2026
Key Statistics
Explore Olink Holding AB (publ) Data
olk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 33.3%
The OLK analyst consensus is Hold, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $21.50, representing -17.56% downside from the current price of $26.08.
Competitors & Peers
olk competitorsStock Performance
Full HistoryAbout Olink Holding AB (publ)
Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical compani…
what is olink holding ab (publ) · olk stock overview · olink holding ab (publ) company profile · who is olink holding ab (publ) ceo · olk NASDAQ · olink holding ab (publ) headquarters · olink holding ab (publ) business segments
About Stock Overview & Key Data
Olink Holding AB (publ) (OLK) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Mar 26, 2021. As of the latest trading session, OLK stock price is $26.08, with a market capitalization of $3.2B. The stock has returned +60.49% over the past 12 months and +4.32% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Olink Holding AB (publ) stock is Hold, with an average 12-month price target of $21.50. In fiscal year 2023, Olink Holding AB (publ) reported revenue of $169.9M and net income of -$31.7M. For detailed data — including Olink Holding AB (publ) revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Olink Holding AB (publ) (OLK) stock price is $26.08. The stock is traded on NASDAQ under the ticker symbol OLK. The 52-week range is $14.10 – $26.09.